These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 17184058)

  • 21. [Value of the determination of activated coagulation time for decreasing heparin and protamine sulfate doses during operations with artificial circulation].
    Savina ME; Piatnitskaia GK; Kukaeva EA; Charnaia MA; Charnyĭ ISh
    Anesteziol Reanimatol; 1981; (5):52-6. PubMed ID: 7325386
    [No Abstract]   [Full Text] [Related]  

  • 22. [A clinical evaluation of the Hepcon/HMS: a new device of monitoring hemostasis management during cardiopulmonary bypass].
    Yamanishi H; Watanabe S; Hayashi K; Tomioka H; Minami M; Nozaki Y; Aoki T; Kawai Y; Kishino K; Ohta S
    Kyobu Geka; 1997 Jun; 50(6):459-62. PubMed ID: 9185440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of anaphylactic shock in an elderly man following protamine sulfate administration during emergent off-pump coronary artery bypass grafting].
    Kudoh O; Warabi K; Yamaguchi K; Ichinose M; Iizuka T; Inada E
    Masui; 2006 May; 55(5):605-10. PubMed ID: 16715917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protamine reaction in a patient undergoing coronary artery bypass grafting.
    Hughes C; Haddock M
    CRNA; 1995 Nov; 6(4):172-6. PubMed ID: 8680346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of twice catastrophic pulmonary vasoconstriction-type shock induced with protamine sulfate].
    Inoue S; Miyashita T; Kuro M
    Masui; 1997 Jul; 46(7):987-90. PubMed ID: 9251520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical effects of different protamine doses after cardiopulmonary bypass.
    Svenarud P; Øvrum E
    Asian Cardiovasc Thorac Ann; 2002 Jun; 10(2):119-23. PubMed ID: 12079933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protamine-associated hypotension in patients on hemodialysis: retrospective study and prevalence of antiprotamine antibodies.
    Tsai YT; Chang LC; Lin YF; Tsai CS; Lai CH; Chen JS
    Clin Nephrol; 2009 Aug; 72(2):122-8. PubMed ID: 19640369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticoagulation management during multivessel coronary artery bypass grafting: a randomized trial comparing individualized heparin management and conventional hemostasis management.
    Hoenicka M; Rupp P; Müller-Eising K; Deininger S; Kunert A; Liebold A; Gorki H
    J Thromb Haemost; 2015 Jul; 13(7):1196-206. PubMed ID: 25954849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety issues in heparin and protamine administration for extracorporeal circulation.
    Jobes DR
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):17-20. PubMed ID: 9583571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surgery under heparin. 3. Incomplete progressive neutralization of heparin at the end of extracorporeal circulation].
    Baille Y; Blanc T; Monties JR; Cohen M; Serra P; Jaquenoud P; Henry E
    Agressologie; 1970; 11(1):87-93. PubMed ID: 5423762
    [No Abstract]   [Full Text] [Related]  

  • 31. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ; Mahadoo J; Jaques LB
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between granulocyte elastase and C3a under protamine dosing in on-pump cardiac surgery.
    Fujii H; Suehiro S; Kumano H; Shibata T; Hattori K; Hirai H; Aoyama T
    Eur J Cardiothorac Surg; 2005 Sep; 28(3):431-4. PubMed ID: 16054381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noncardiogenic pulmonary edema immediately following rapid protamine administration.
    Brooks JC
    Ann Pharmacother; 1999 Sep; 33(9):927-30. PubMed ID: 10492491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of protamine dose assay in reversal of heparin following extracorporeal circulation for open heart surgery.
    Lee CN; Goh BL; Chin LG; Tan C; Woo M; Boey WK; Lee E; Kuah B
    Ann Acad Med Singap; 1990 Jan; 19(1):41-4. PubMed ID: 2327723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin rebound. Studies in patients and volunteers.
    Ellison N; Beatty CP; Blake DR; Wurzel HA; MacVaugh H
    J Thorac Cardiovasc Surg; 1974 May; 67(5):723-9. PubMed ID: 4823307
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of site of venous protamine administration, previously alleged risk factors, and preoperative use of aspirin on acute protamine-induced pulmonary vasoconstriction.
    Comunale ME; Maslow A; Robertson LK; Haering JM; Mashikian JS; Lowenstein E
    J Cardiothorac Vasc Anesth; 2003 Jun; 17(3):309-13. PubMed ID: 12827577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial effects of protamine.
    Avellanal M; Barrigón S
    J Cardiothorac Vasc Anesth; 2007 Oct; 21(5):779. PubMed ID: 17905299
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparison of methods to calculate the heparin reversal dose of protamine in cardiovascular surgery.
    Gundry SR; Drongowski R; Coran AG; Kirsh MM; Klein MD
    Trans Am Soc Artif Intern Organs; 1985; 31():143-5. PubMed ID: 3837433
    [No Abstract]   [Full Text] [Related]  

  • 40. Protamine--antagonist to heparin.
    Jaques LB
    Can Med Assoc J; 1973 May; 108(10):1291-7. PubMed ID: 4122234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.